Complex clonal shifts including mitochondrial metabolic reprogramming with altered expression of the AMPK signaling pathway, or mutations in BTG1 and aberrations of CDKN2A/B have been observed in venetoclax-resistant CLL [66,71]. The gene discussed is CDKN2A; the disease is B-cell chronic lymphocytic leukemia.